Last Update 11 May 26

SNBR: Marketing And Product Reset Will Support Future Earnings Recovery Potential

Analysts have trimmed their price targets on Sleep Number to a range of about $4 to $5. This reflects increased caution as recent marketing and product efforts have yet to show clear sales momentum.

Analyst Commentary

Recent Street commentary around Sleep Number reflects a mixed view, with price targets now grouped around the mid single digits and ratings held at Neutral. Analysts are weighing early signs of progress in marketing and product efforts against the lack of clear improvement in sales trends.

Bullish Takeaways

Bullish analysts point to the Q4 revenue and EBITDA beat as a sign that the company can still execute against its cost and margin plans, which helps support the current valuation even with a lower price target range.
Some see the ongoing work on marketing spend and new product launches as early building blocks for future growth, even if that progress has not yet flowed through to sales.
The decision to maintain Neutral ratings, rather than move to Underweight or Sell, suggests analysts view the recent reset in expectations and price targets as bringing the stock closer to what they see as fair value.
For investors, the trimmed price targets around US$4 to US$5 can be read as analysts trying to align their models more closely with current execution and demand conditions rather than writing off the company’s long term potential.

Bearish Takeaways

Bearish analysts focus on the sizeable cut in price targets, from prior levels around US$10 to US$12 down to US$4 to US$5, as a signal that near term growth and profitability expectations have been materially reset.
The key concern is that increased marketing spend and new products have not yet translated into better sales, which raises questions about the effectiveness and timing of these initiatives.
With ratings held at Neutral rather than upgraded, analysts are signaling that they see limited visibility on a clear sales rebound, which may cap how much investors are willing to pay for the stock until trends improve.
Overall, the commentary highlights execution risk around turning marketing and product investments into sustained revenue growth, a factor that can weigh on valuation until the company shows more consistent sales traction.

What’s in the News

Sleep Number rolled out its redesigned mattress portfolio nationwide in stores and online, featuring three collections, ComfortMode, ComfortNext, and Climate, with a total of seven beds and a streamlined lineup intended to make choices simpler for customers (Key Developments).
The new beds include the company’s first Tri-Brid design that combines micro coils, foam, and air, with a focus on support, personalized adjustability, temperature features, and value at various price points across the three collections (Key Developments).
In its 10-K filed on March 12, 2026, Sleep Number’s auditor, Deloitte & Touche LLP, issued an unqualified opinion that also expressed doubt about the company’s ability to continue as a going concern (Key Developments).
The company reported that from September 28, 2025 to January 3, 2026 it repurchased 0 shares for US$0, while total repurchases under the long running buyback initiated in 2006 reached 50,132,467 shares for US$1.77b (Key Developments).

Valuation Changes

Fair Value: Model fair value is held at $4.50, with no change from the prior estimate.
Discount Rate: The discount rate has risen slightly from 12.33% to 12.46%, which implies a modestly higher required return in the updated model.
Revenue Growth: Forecast revenue growth remains effectively unchanged at about 2.96%.
Net Profit Margin: The projected net profit margin is essentially unchanged at about 1.84%.
Future P/E: The future P/E assumption has risen slightly from 5.17x to 5.19x, which reflects a marginally higher valuation multiple in the model.

2 views

Key Takeaways

High debt and limited capital flexibility, combined with lack of near-term growth drivers, threaten margins and risk future earnings as macro pressures persist.
Efforts to broaden distribution and simplify offerings could weaken brand differentiation and innovation, making Sleep Number vulnerable to intensified competition and commoditization.
Enhanced marketing efficiency, cost discipline, product simplification, omni-channel expansion, and proprietary tech position Sleep Number for resilient growth, margin improvement, and broader market relevance.

Catalysts

About Sleep Number

Designs, manufactures, markets, distributes, retails, and services sleep solutions in the United States.What are the underlying business or industry changes driving this perspective?

Management signals a long path to top-line recovery despite ongoing cost cuts; with flat second-half revenues expected and no material growth initiatives realized until 2026, investor optimism around near-term revenue growth and operating leverage appears unfounded, putting forward multiples at risk. (Impacts: Future sales, operating margins)
The company's strategy to broaden distribution-including digital-first, retail partnerships, and emerging platforms-may dilute brand differentiation and margin structure, especially as competition in smart bed and connected home categories intensifies and price pressure from commoditized DTC models increases. (Impacts: Gross margins, average selling price, long-term revenue growth)
High debt burden and dependence on favorable lender negotiations continue to constrain capital allocation flexibility, making long-term investments in innovation or large-scale channel expansion riskier and increasing the likelihood of future margin and earnings compression if macro conditions or lender terms tighten. (Impacts: Interest expenses, net margins, long-term earnings)
CEO and CFO emphasized needing to make the product assortment, pricing, and retail experience simpler and more accessible to reach a broader customer base, implicitly acknowledging that demographic shifts-such as the aging U.S. population, slower homeownership growth, and greater renting-are already pressuring Sleep Number's premium positioning and suppressing addressable market growth. (Impacts: Sales volume, average selling price, revenue growth)
Rapid operational restructuring, including deep G&A and R&D cuts, risks eroding Sleep Number's innovation pipeline and long-term competitive moat, especially as larger industry trends drive increased integration of IoT, AI, and health-tracking into sleep products-potentially leading to brand commoditization and weaker gross margins if competitors outpace Sleep Number in R&D. (Impacts: Long-term gross margins, competitive positioning, innovation-driven revenue)

Sleep Number Earnings and Revenue Growth

Sleep Number Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Sleep Number's revenue will grow by 3.0% annually over the next 3 years.
Analysts assume that profit margins will increase from -9.3% today to 1.8% in 3 years time.
Analysts expect earnings to reach $28.4 million (and earnings per share of $1.1) by about May 2029, up from -$132.0 million today.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 5.3x on those 2029 earnings, up from -0.5x today. This future PE is lower than the current PE for the US Specialty Retail industry at 19.7x.
Analysts expect the number of shares outstanding to grow by 0.9% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 12.46%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

Significant improvements in marketing efficiency-including a 24% increase in conversion year-over-year and ongoing optimization of programs, channels, and customer targeting-could drive higher future revenue without proportionally increasing spend, boosting both top-line and margins over time.
Aggressive cost reduction efforts ($130 million targeted in 2025) through streamlining G&A, R&D, and organizational layers, as well as supply chain and manufacturing efficiencies, have already led to improved EBITDA margins; further discipline in cost management may continue to expand net margins and earnings, even in a soft sales environment.
Plans to enhance and simplify the product lineup, backed by proprietary sleep data and ongoing customer research, position the brand to broaden its addressable market and improve relevance and conversion, supporting future revenue growth as consumer demand for personalized wellness products rises.
Commitment to omni-channel expansion-including new digital-first partnerships and a holistic ecosystem approach-has the potential to drive market share gains and reduce dependence on any single retail channel, supporting resilient revenue growth and potentially lowering distribution costs long-term.
Strength in proprietary technology (SleepIQ®), historical gross margin improvements despite unit deleverage, and an explicit focus on innovation and product differentiation, position Sleep Number to benefit from ongoing secular trends in health, wellness, and connected home adoption, which could underpin long-term revenue and margin expansion.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $4.5 for Sleep Number based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $5.0, and the most bearish reporting a price target of just $4.0.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $1.5 billion, earnings will come to $28.4 million, and it would be trading on a PE ratio of 5.3x, assuming you use a discount rate of 12.5%.
Given the current share price of $2.85, the analyst price target of $4.5 is 36.7% higher.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Sleep Number?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Despite Margin Risks, Digital Shifts Will Drive Future Turnaround